These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22833902)

  • 1. Poly(amidoamine) polymers: soluble linear amphiphilic drug-delivery systems for genes, proteins and oligonucleotides.
    Pettit MW; Griffiths P; Ferruti P; Richardson SC
    Ther Deliv; 2011 Jul; 2(7):907-17. PubMed ID: 22833902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(amidoamine) Dendrimers as a Pharmaceutical Excipient. Are We There yet?
    Otto DP; de Villiers MM
    J Pharm Sci; 2018 Jan; 107(1):75-83. PubMed ID: 29045886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of branched or linear architecture of bioreducible poly(amido amine)s on their in vitro gene delivery properties.
    Martello F; Piest M; Engbersen JF; Ferruti P
    J Control Release; 2012 Dec; 164(3):372-9. PubMed ID: 22846986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated thermo-sensitive poly(amidoamine) dendritic drug delivery systems.
    Zhao Y; Fan X; Liu D; Wang Z
    Int J Pharm; 2011 May; 409(1-2):229-36. PubMed ID: 21316434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
    Hennig R; Veser A; Kirchhof S; Goepferich A
    Mol Pharm; 2015 Sep; 12(9):3292-302. PubMed ID: 26252154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(amidoamine)s as potential nonviral vectors: ability to form interpolyelectrolyte complexes and to mediate transfection in vitro.
    Richardson SC; Pattrick NG; Man YK; Ferruti P; Duncan R
    Biomacromolecules; 2001; 2(3):1023-8. PubMed ID: 11710005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(amido amine) dendrimers in oral delivery.
    Yellepeddi VK; Ghandehari H
    Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells.
    Seib FP; Jones AT; Duncan R
    J Control Release; 2007 Feb; 117(3):291-300. PubMed ID: 17210200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photocrosslinked poly(amidoamine) nanoparticles for central nervous system targeting.
    Gevorgyan S; Rossi E; Cappelluti MA; Tocchio A; Martello F; Gerges I; Lenardi C; Milani P; Argentiere S
    Colloids Surf B Biointerfaces; 2017 Mar; 151():197-205. PubMed ID: 28013163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(amidoamine) salt form: effect on pH-dependent membrane activity and polymer conformation in solution.
    Wan KW; Malgesini B; Verpilio I; Ferruti P; Griffiths PC; Paul A; Hann AC; Duncan R
    Biomacromolecules; 2004; 5(3):1102-9. PubMed ID: 15132705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and endosomolytic properties of poly(amidoamine) block copolymers.
    Lavignac N; Lazenby M; Foka P; Malgesini B; Verpilio I; Ferruti P; Duncan R
    Macromol Biosci; 2004 Oct; 4(10):922-9. PubMed ID: 15495179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.
    Xu Q; Wang CH; Pack DW
    Curr Pharm Des; 2010 Jul; 16(21):2350-68. PubMed ID: 20618156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresponsive poly(amidoamine)s designed for intracellular protein delivery.
    Coué G; Freese C; Unger RE; Kirkpatrick CJ; Engbersen JF
    Acta Biomater; 2013 Apr; 9(4):6062-74. PubMed ID: 23237985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
    Rompicharla SVK; Kumari P; Ghosh B; Biswas S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of dendrimers in delivery of genes and drugs.
    Gao Y; Gao G; He Y; Liu T; Qi R
    Mini Rev Med Chem; 2008 Aug; 8(9):889-900. PubMed ID: 18691146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of biologics to select organelles--the role of biologically active polymers.
    Dyer PD; Richardson SC
    Expert Opin Drug Deliv; 2011 Apr; 8(4):403-7. PubMed ID: 21314493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized linear poly(amidoamine)s are efficient vectors for intracellular protein delivery.
    Coué G; Engbersen JF
    J Control Release; 2011 May; 152(1):90-8. PubMed ID: 21277918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
    Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
    Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.